ANN ARBOR, Mich., April 13, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that senior management is traveling to South East Asia this week to build on the momentum of its recently announced record-setting production of 1.3 metric tons of recombinant spider silk cocoons in a single month.

The visit follows the Company’s successful delivery on the aggressive production targets it outlined earlier this year. The 1.3 metric ton milestone represents not only a record-setting achievement but a clear validation of the Company’s execution strategy and operational scale-up model.

During the trip, management will conduct a detailed review of the most recent production cycle, including output quality, yield performance, and processing efficiency. The team will also oversee downstream processing of its recombinant spider silk cocoons into reeled silk, a critical step in transforming raw production into commercial-ready materials.

In addition, management will meet with leadership at Prodigy Silk, Kraig Labs’ subsidiary, and key representatives from the Company’s expanding production network. These meetings will focus on near-term expansion planning, strengthening coordination across the production pipeline, and identifying opportunities to further accelerate growth.

“We set a plan, we delivered, and now we are moving immediately to expand on that success,” said Kim Thompson, Founder and CEO of Kraig Labs. “This trip is about turning a major milestone into a Launchpad for what comes next.”

While achieving 1.3 metric tons marks a significant step forward, the Company emphasized that this milestone is not an endpoint but a waypoint on its near-term roadmap. Kraig Labs remains focused on rapidly advancing toward its stated goal of reaching 10 metric tons of monthly production.

“Our roadmap has always been clear,” Thompson continued. “This level of production demonstrates that our systems work, our partnerships are strong, and our strategy is sound. The work we are doing now is about scaling faster, refining processes, and closing the gap to our next major production target.”

The Company expects insights from this visit to directly inform upcoming production cycles and further strengthen its ability to scale recombinant spider silk output to unprecedented levels.

---

The Company leadership in bioengineering was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of its work in scaling spider silk production.

Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.

You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

Record-breaking output validates aggressive scale-up strategy as Company accelerates toward 10 metric tons per month

ANN ARBOR, Mich., April 6, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that it has produced more than 1.3 metric tons of recombinant spider silk cocoons in a single month. This is a new world record and shatters the Company’s previous production record by a factor of five. Today marks a pivotal step forward in the transition of spider silk from laboratory innovation to an industrial-scale material platform.

When Kraig Labs unveiled its 2026 production plan in February, the Company committed to an aggressive timeline to scale spider silk output to multi-ton commercial volumes. Today’s announcement confirms that Kraig Labs is delivering on that commitment.

“This is a defining moment for our Company and for the future of advanced materials. We told the market we were going to scale fast, and that is exactly what we are doing,” said Kim Thompson, Founder and CEO of Kraig Labs. “Crossing the one metric ton mark in a single month is a massive commercialization milestone. This is real production at scale. Recombinant spider silk commercialization isn’t coming, it’s here.”

The Company reported that the production ramp was completed without operational disruptions or delays. Expanded facilities and newly deployed BAM-1 Alpha production hybrids performed as designed, with output meeting or exceeding internal benchmarks at every stage. This seamless execution reflects years of investment in scalable infrastructure, proprietary production strains, and vertically integrated operations.

Each phase of the Company’s scale-up has now been validated in the field, building a foundation for continued acceleration.

“This wasn’t a one-off. This was a pressure test of our entire system, our facilities, our hybrids, our team, and every piece delivered,” Thompson added. “We built this platform and a technology designed for scale, and the results speak for themselves.”

With the one metric ton threshold now cleared, Kraig Labs is driving toward its next major target: 10 metric tons of spider silk cocoon production per month. The Company expects to reach that level within the coming months, unlocking significant commercial opportunities across technical textiles, performance apparel, and other applications.

At that scale, Kraig Labs believes spider silk will move from a breakthrough biomaterial to a widely available, high-performance industrial fiber. A material that has no equal; lightweight, exceptionally strong, and sustainably produced.

“Our trajectory is accelerating,” Thompson concluded. “We are building something the world has never seen before, and we’re doing it faster than most thought possible.”

---

The Company leadership in bioengineering was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of its work in scaling spider silk production.

Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.

You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., March 30, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced the successful deployment of more than 700,000 BAM-1 Alpha production hybrids of its previously reported 1,000,000 egg inventory.  These silkworms are now in active production. This achievement underscores the Company’s continued execution of its previously announced plan for rapid production expansion of recombinant spider silk. The Company seeks to increase output to metric ton levels.

In February, Kraig Labs outlined an aggressive pathway to dramatically increase recombinant spider silk production. Today’s announcement confirms that the Company is solidly on track, having achieved a key milestone by releasing more than 700,000 production hybrids in a single month.

“This is exactly the kind of disciplined, structured, and milestone-driven execution we set out to achieve,” said Kim Thompson, Founder and CEO of Kraig Labs. “We laid out an ambitious plan to scale production to unprecedented levels, and we are now systematically delivering against that roadmap. The rapid deployment of more than 700,000 BAM-1 Alpha hybrids represents a major step forward as we move toward our goal of producing spider silk at metric ton levels.”

Kraig’s production team has reported that the BAM-1 Alpha hybrids are performing exceptionally well, exceeding internal expectations for robustness and productivity. These results further validate the Company’s decision to center its scale-up strategy around the BAM-1 Alpha platform.

Kraig Labs has emphasized a systematic, milestone-based approach to achieving its long-term production targets. Each phase of expansion is designed to build upon prior successes, ensuring stability and repeatability as output increases.

With the successful deployment of this latest production run, the Company continues to advance toward its objectives. Management believes that its current trajectory positions the Company to achieve this target on an accelerated timeline.

“We see these results as a clear demonstration that our strategy is working,” Thompson added. “We are executing an aggressive plan, hitting our milestones, and moving with purpose toward industrial-scale commercial spider silk production.”

______________________________________________________________________

The Company’s leadership in bioengineering was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of its work in scaling spider silk production.

Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.

You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., March 23, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced a significant expansion of its research and development capacity designed to keep pace with rapid progress of its advanced materials initiative, Project Atlas.

The Company has expanded its laboratory capabilities, onboarding new scientific personnel and the deployment of new advanced equipment. These improvements have roughly tripled screening throughput, allowing the R&D team to keep up with the rapid development of new transgenics.

Kraig Labs implemented these upgrades in direct response to the rapid technical progress made under Project Atlas. Atlas is the Company’s next-generation recombinant spider silk program focused on creating advanced biomaterials with potential industrial and defense applications.

The recently commissioned equipment streamlines the screening of newly created transgenic lines and the analysis of their resulting spider silk expression levels. Project Atlas is now generating significant numbers of transgenics and potential candidates for new production materials. This expanded screening capacity was needed to keep pace with the rate of new transgenic creation, which is now at the highest levels in the Company’s history. By automating portions of the testing workflow, Kraig Labs can now rapidly process and evaluate significantly more samples, quickly identifying new, exciting transgenics.

In addition to the increased screening capacity, Kraig Labs also strengthened its analytical testing capabilities. These tools provide deeper insight into the expression levels and functional impact of each engineered transgenic line. This enhanced visibility allows the research team to identify the most promising genetic designs and prioritize them for advancement into the Company’s production pipeline.

“With the pace of discovery we are seeing in Project Atlas, it became clear that we needed to expand our screening and analysis capacity to keep up with the speed of innovation,” said Kim Thompson, Founder and CEO of Kraig Labs. “This investment in staff and technology further strengthens our position as a leader in advanced biomaterials. We believe we have a wide lead on our competitors, and it is the goal of this investment to expand that lead further.”

Dr. Zhang, the Company’s Chief Scientist, emphasized the impact these upgrades will have on the research pipeline.

“Project Atlas involves the creation and evaluation of numerous complex genetic constructs designed to work together to produce highly specialized silk proteins,” said Dr. Zhang. “The expansion of our testing infrastructure dramatically increases our testing capacity to match the increased pace of transgenic creation. We can now analyze many more transgenic lines in parallel and better quantify how each genetic insert is performing. This level of screening power is essential for isolating the highest-performing lines and rapidly advancing them into production.”

By significantly increasing screening capacity and analytical insight, Kraig Labs expects to shorten development timelines and improve its ability to identify breakthrough material candidates.

The Company leadership in bioengineering was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of its work scaling spider silk production.

Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.

You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., March 5, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced a major milestone in “Project Atlas”, the Company’s next-generation bioengineering initiative aimed at creating entirely new classes of materials for industrial and defense applications.

Kraig Labs first disclosed the existence of Project Atlas on January 19^th, 2026, when it was already at an advanced stage of development. The Company described an ambitious effort to merge numerous complex genetic elements into a single integrated architecture. Project Atlas seeks to create new super materials with enhanced strength, toughness, and other properties. Today, Kraig Labs confirms Project Atlas has passed its most critical milestone and is moving forward at full speed.

Project Atlas employs numerous genetic modifications operating in tandem to create an entirely new class of materials. The result is a powerful new approach to biomaterial development, opening the door to entirely new performance capabilities.

“This project represents what I believe is the most advanced molecular biology work ever undertaken in material science,” said Kim Thompson, Founder and CEO of Kraig Labs. “We are creating an advanced platform, where multiple components work in unison to achieve very specific material outcomes. That level of coordinated engineering has never been attempted before in spider silk or biomaterials, to our knowledge.”

Atlas has already resulted in the creation of multiple new transgenic lines, which are now progressing through the Company’s evaluation pipeline.

Early results have reinforced management’s confidence that Project Atlas will reshape the future of biomaterial development and significantly broaden the applications for spider silk and other super fibers.

This latest breakthrough comes as Kraig Labs continues to receive global recognition for its pioneering work in bioengineered spider silk. The Company was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of its work in bioengineering and scaling spider silk production.

**

With Project Atlas now moving into its next phase, Kraig Labs expects continued rapid progress as the program advances toward the creation of new materials designed to meet demanding industrial and defense performance requirements.

Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.

You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering

** Photography by Mark Thiessen, NGM Staff, Image Copyright: National Geographic Magazine

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., February 23, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that its groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Geographic magazine.

National Geographic highlights Kraig Labs’ advancements in producing spider silk fibers using genetically enhanced silkworms. The article includes a graphic that describes the significant advantages of a silkworm-based platform (Kraig Labs Technology). Those advantages include being the most cost-efficient and highest-quality technology for commercializing spider silk. This breakthrough approach combines the scalability of silkworm cultivation with the exceptional performance properties of spider silk. The feature explores both the technical advantages of Kraig’s approach and the growing commercial opportunities of spider silk biomaterials.

Being recognized by a publication with the global reach and historic legacy of National Geographic represents a major milestone for Kraig Labs and for the broader field of biomaterials innovation.

Kraig Labs hosted a team from National Geographic at the Company’s research center for three days of interviews, facility tours, and photography. That visit resulted in the striking cover image and an in-depth feature exploring the science and progress behind next-generation spider silk materials. During their visit, Kraig Labs recombinant spider silk was put to the test, towing a car across a parking lot and suspending a person from the ceiling on a single 0.35-ounce loop of thread. 

Due to strict confidentiality and publication agreements, the Company was unable to discuss this publicly until the issue was officially released. Kraig Labs is now proud to share this achievement with its shareholders and partners.

Kraig Labs extends its sincere thanks to the entire National Geographic editorial and photography team for their professionalism and dedication in bringing this story to a global audience.

**

“We are honored to have our work recognized by one of the world’s most respected publications. Our recombinant spider silk technology holds amazing potential across numerous applications from apparel to medicines, industry, and defense technologies,” said Kim Thompson, Kraig Labs CEO, founder, and inventor of the technology. “With our production operations set to kick into high gear, our team is eager to begin supplying the markets with this amazing material.”

Kraig Labs continues to advance commercialization of its recombinant spider silk technologies as global interest grows in high-performance, sustainable fiber and fabric solutions.

Interested persons can order a copy of the magazine from National Geographic at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.

You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering

** Photography by Mark Thiessen, NGM Staff, Image Copyright: National Geographic Magazine

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., February 17, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that its 2026 production plan has officially moved from strategy to execution.

The Company has now moved bio-material to incubation, getting a jumpstart on its March production plan and formally initiating its multi-ton spider silk scale-up initiative.

This milestone follows Kraig’s recently announced 2026 production schedule. This aggressive plan is set to achieve sustained monthly production of recombinant spider silk cocoons at unprecedented commercial volumes. With the release of the first wave of production materials now complete, Kraig Labs has activated its expanded manufacturing pipeline and commenced field-level implementation.

“This is the moment where planning becomes production,” said Kim Thompson, Kraig Labs CEO and Founder. “Our 2026 roadmap was built around disciplined expansion, operational efficiency, and multi-ton output. Today, that roadmap is in motion. Bio-materials have recently been moved to incubation in preparation for the March production run.”

The March production run represents the first major deployment under the Company’s 2026 plan. The initiative is designed to drive consistent output at levels never before seen, while reinforcing quality control, supply chain stability, and downstream processing capacity.

By initiating this production cycle, Kraig Labs is delivering on its commitment, creating the world’s first reliable, repeatable, and scalable commercial spider silk manufacturing. The Company’s vertically integrated model enables rapid deployment of materials, controlled expansion of silkworm rearing operations, and alignment with future customer demand.

“Our focus is clear,” Thompson continued. “Execution. Volume. Commercialization. Every production cycle strengthens our position as the global leader in recombinant spider silk.”

Kraig Labs expects this March run to set the pace for subsequent production cycles throughout 2026, forming the foundation for sustained monthly metric-ton-level spider silk production.

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

2026 Production Plan Set for a record 10 Metric Tons of Recombinant Spider Silk Cocoon Per Month

ANN ARBOR, Mich., February 9, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced its 2026 production plan that will drive explosive growth and establish a new global benchmark for spider silk manufacturing.

Kraig’s technology is built upon the use of modified silkworms to produce recombinant spider silk. Within the next 30 days, the Company will begin large-scale deployment of its stockpile of proprietary spider silk silkworm eggs. Production plans are now fully in place. Release is scheduled to begin the first week of March. Spider silk output is expected to ramp rapidly, with Kraig Labs hitting full output of 10 metric tons of recombinant spider silk cocoon per month by May.

At full capacity, this level of sustained spider silk output represents a scale that has never been seen before. No company has ever operated anywhere close to this volume of naturally spun recombinant spider silk. This production program is a true game changer for the commercialization of spider silk and firmly positions Kraig Labs as the world leader in this field.

Kraig Labs is committed to sustaining this operational capacity with plans for adding even more production capacity later in 2026.

Kraig Labs has engineered and refined proprietary production strains designed for durability, consistency, and high yields of recombinant spider silk. These production lines have been advanced through repeated rearing cycles to ensure stability, resilience, and dependable performance at an industrial scale.

In parallel, the Company has made substantial investments in facilities, workforce expansion, and vertically integrated production infrastructure. Together, these elements form a manufacturing platform built for scale and execution. Kraig Labs has unlocked an entirely new standard for spider silk production.

“This is the most exciting and ambitious program for spider silk production the world has ever seen. Achieving multi-ton level output unlocks key markets and sales channels,” said Kim Thompson, Founder and CEO of Kraig Labs. “We are setting standards for spider silk production that were previously thought unreachable. This is a defining moment for our Company and spider silk technology. We believe this will be a transformative moment for Kraig Labs and the commercialization of spider silk.”

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is built on a scientifically engineered silkworm which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., January 19, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that it is entering the new year with the implementation of the most ambitious and advanced genetic engineering initiative ever undertaken by the Company. The focus of this project is to dramatically increase strength and elasticity beyond anything ever seen in the area of recombinant spider silk.

The Company reported that its research and development team has successfully completed the construction phase of the most advanced spider silk gene constructs in Kraig’s history. With this milestone achieved, Kraig Labs has now begun the active execution phase of what represents the next evolution in silkworm gene engineering and recombinant spider silk production.

This initiative, now well underway, represents the largest and most complex silkworm gene-engineering project ever undertaken globally. The program builds upon years of proprietary research and production experience and is designed to further expand the performance, scalability, and commercial potential of the Company’s spider silk technologies.

“This project represents a defining moment for our technology platform,” said Kim Thompson, Founder and CEO of Kraig Labs. “Our team has completed the most sophisticated spider silk gene constructs we have ever developed, and we are now advancing into the next phase, creating new materials that we believe will significantly expand the boundaries of what is possible in spider silk production. I believe this is the most ambitious application of genetic engineering to material science in world history and that this work will eclipse anything else being done in biomimicry or applications of molecular biology to material science.”

The new genetic engineering program is intended to drive continued innovation across the Company’s production pipeline, supporting enhanced fiber performance and future product diversification. Kraig Labs expects this effort to further strengthen its leadership position as it advances toward sustained commercial-scale spider silk manufacturing.

“This initiative reflects the depth of our expertise and our long-term commitment to innovation,” Thompson added. “As we continue to advance commercialization of our current product offerings, we are simultaneously investing in the technologies that will define the next generation of spider silk.”

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about other recent Kraig Labs advancements, please watch the Company’s investor conference at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., January 12, 2026 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that it has taken possession of its third silkworm rearing center, completing the core physical infrastructure upgrades, underpinning the Company’s massive recombinant spider silk production scale-up planned for 2026.

This newest facility represents the final major component of the Company’s multi-year production expansion strategy. With three fully operational rearing centers, Kraig Labs will be able to run three simultaneous production cycles, providing both production diversity and the capacity required to meet and exceed one metric ton of finished spider silk per month.

This production scale-up, now well underway, is the culmination of years of development and refinement. Each element of the Company’s expansion, including facility design, staffing, geographic location, operational workflows, and training programs, has been optimized based on lessons learned from prior production campaigns.

The newly acquired facility is the largest single-site rearing center the Company has ever operated. This new facility is designed to support significantly higher throughput while maintaining the operational discipline and biological consistency required for large-scale spider silk manufacturing. This facility is expected to unlock the next level of production capacity as the Company rapidly accelerates spider silk output.

Importantly, this new rearing center has been strategically positioned to leverage the Company’s recently acquired mulberry fields, which will supply the expanded feedstock necessary to support this substantial increase in silkworm and spider silk production. These mulberry resources form a critical foundation of the Company’s vertically integrated production model and are expected to play a key role in enabling continuous, high-volume operations across all of its facilities.

The Company is now bringing this new rearing center online and expects to begin operations later this quarter.

“This milestone represents a critical step forward in our evolution as a world-leading supplier of spider silk,” said Kim Thompson, Kraig Labs Founder and CEO. “With this final rearing center secured and supported by expanded mulberry cultivation, we now have the infrastructure and feedstock capacity in place to support continuous, scalable production at levels that position Kraig Labs to fulfill our vision of commercially scalable and cost-effective spider silk production.”

The Company expects to provide additional updates as the facility is commissioned and fully integrated into its 2026 production campaign.

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about other recent Kraig Labs advancements, please watch the Company’s investor conference at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link  https://www.kraiglabs.com/world-leader/

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com